We examined how different blood pressure metrics associated with molecular markers of astrocytic activation (GFAP), neuronal axon breakdown (NfL), and Alzheimer’s disease pathobiology (pTau181, Aβ42/40) in plasma. The gene discussed is GFAP; the disease is early-onset autosomal dominant Alzheimer disease.